ELEVIDYS
NDC 60923-538, delandistrogene moxeparvovec-rokl, kit, from Sarepta Therapeutics, Inc..
- Product NDC
- 60923-538
- Status
- Listed
- Labeler
- Sarepta Therapeutics, Inc.
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125781
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60923-538 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60923-538-47 | 60923053847 | 1 KIT in 1 CARTON (60923-538-47) * 10 mL in 1 VIAL, SINGLE-USE (60923-562-01) * 47 POUCH in 1 BOX / 1 SWAB in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3525abcd-fbd2-46c5-9706-cffdf2e8a361
Use it
Look up 60923-538 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60923-538 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60923-538. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.